Platelet dysfunction in intraparenchymal hemorrhage
- PMID: 19797180
- PMCID: PMC8930190
- DOI: 10.1161/STROKEAHA.109.561191
Platelet dysfunction in intraparenchymal hemorrhage
Comment on
-
Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage.Stroke. 2009 Jul;40(7):2398-401. doi: 10.1161/STROKEAHA.109.550939. Epub 2009 May 14. Stroke. 2009. PMID: 19443791
References
-
- Broderick JP. Evidence against rapid reversal of antiplatelet medications in acute intracerebral hemorrhage. Neurology. 2009;72:1376–1377. - PubMed
-
- Saloheimo P, Ahonen M, Juvela S, Pyhtinen J, Savolainen ER, Hillbom M. Regular aspirin-use preceding the onset of primary intracerebral hemorrhage is an independent predictor for death. Stroke. 2006;37:129–133. - PubMed
-
- Toyoda K, Okada Y, Minematsu K, Kamouchi M, Fujimoto S, Ibayashi S, Inoue T. Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage. Neurology. 2005;65:1000–1004. - PubMed
-
- Lacut K, Le Gal G, Seizeur R, Prat G, Mottier D, Oger E. Antiplatelet drug use preceding the onset of intracerebral hemorrhage is associated with increased mortality. Fundam Clin Pharmacol. 2007;21:327–333. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
